Loading...
OTCM
GLPGF
Market cap1.81bUSD
, Last price  
USD
Name

Galapagos NV

Chart & performance

D1W1MN
OTCM:GLPGF chart
P/E
—
P/S
—
EPS
4.87
Vol. 1Y
—
Shs. 5Y
0.25%
Rev. 5Y
18.40%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.11b
+303.35%
35,152,00065,936,00076,978,00093,089,000122,410,00095,887,000136,268,000137,699,00069,368,00039,563,000129,517,000127,087,000288,836,000834,901,000478,053,000484,846,000241,249,000239,724,000275,649,0001,111,831,419
Net income
321m
+332.98%
-11,335,000-21,948,000-14,584,0003,010,0004,370,000-33,097,000-5,721,000-8,079,00033,211,000-118,410,00054,012,000-115,704,000-29,259,000149,845,000-305,436,000-125,422,000-217,991,000211,697,00074,082,000320,763,815
CFO
-197m
L-38.46%
-9,310,000371,000-8,209,0006,303,000-18,573,000-11,991,00064,104,000522,000-75,555,000-114,590,000239,403,000-147,030,000-142,466,0003,596,902,458-427,336,000-503,827,000-500,544,000-405,970,000-320,026,000-196,934,212

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Related entities

Subsidiaries
Galapagos Cell Therapeutics

Key people

Aaron Cox
Chief Financial Officer · since 2025
Valeria Cnossen
Executive Vice President, General Counsel, Member of the Management Board · since 2023
Fred Blakeslee
Executive Vice President, General Counsel · since 2025
Henry Gosebruch
Chief Executive Officer, Executive Director · since 2025
Dan Grossman
Chief Strategy Officer · since 2025
Sooin Kwon
Chief Business Officer · since 2025
Annelies Missotten
Chief Human Resources Officer, Executive Vice President, Member of the Management Board · since 2023
Andrew Dickinson
Non-Executive Non-Independent Director · since 2024
Linda Higgins
Non-Executive Non-Independent Director · since 2019
Oleg Nodelman
Non-Executive Non-Independent Director · since 2024
Devang Bhuva
Non-Executive Independent Director · since 2025
Jerome Contamine
Lead Non-Executive Independent Director · since 2023
Jane Griffiths
Non-Executive Independent Director · since 2025
Peter Guenter
Non-Executive Independent Director · since 2019
Susanne Schaffert
Non-Executive Independent Director · since 2023
Simon Sturge
Non-Executive Independent Director · since 2023
Dawn Svoronos
Non-Executive Independent Director · since 2025
URL
https://www.glpg.com/
IPO date
May 06, 2005
Employees
1,233
Domiciled in
BE
Incorporated in
BE
Headquarters & legal address
Schaliënhoevedreef 20T
Mechelen 2800
BE
Previous name
GALAPAGOS

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT